FDA Approved: APLENZIN — Supplemental Application (Bausch Health US, LLC)

View source ↗

Summary

FDA approved a supplemental application for APLENZIN (bupropion hydrobromide) from Bausch Health US, LLC. This action updates the product labeling under the sup…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Seasonal Affective Disorder

Drugs mentioned

• APLENZIN (BUPROPION HYDROBROMIDE)

Snippet

SUPPL AP for APLENZIN (BUPROPION HYDROBROMIDE)